Search
for

    Sort by

    Research 451–480 of 1000+

    1. Androgenic alopecia may have evolved to protect men from prostate cancer by increasing skin exposure to ultraviolet radiation Medical Hypotheses · 2007 · 6 citations
    2. Hemorrhagic cystitis in allogeneic stem cell transplantation: a role for age and prostatic hyperplasia Supportive Care in Cancer · 2022 · 5 citations
    3. Relative binding affinity of novel steroids to androgen receptors in hamster prostate Journal of Enzyme Inhibition and Medicinal Chemistry · 2005 · 5 citations
    4. Relationship of Serum Prostate Specific Antigen with Hirsutism in Women Having Polycystic Ovary Syndrome Belonging to the Province of Khyber Pakhtunkhwa, Pakistan Journal of Liaquat University of Medical & Health Sciences · 2023
    5. Implicações da toma crónica da Finasteride para a Alopécia Androgenética no Carcinoma da Próstata 2015
    6. Finasteride para disminuir el sangrado en resección transuretral de próstata en pacientes con sonda Foley Revista del Hospital Juárez de México · 2014
    7. 1408 INDUCTION OF SECRETED WNT FACTOR WISP1/CCN4 BY HUMAN PROSTATE STROMAL CELLS BY MICROENVIORNMENTAL HYPOXIA The Journal of Urology · 2010
    8. 1406 DETECTION OF MEMBRANE ANDROGEN-BINDING SITE IN LIVING RAT PROSTATE AND EVALUATION OF ITS ROLE IN PROSTATE BLOOD FLOW REGULATION The Journal of Urology · 2010
    9. 1407 ANDROGENETIC ALOPECIA, PROSTATE VOLUME AND URINARY SYMPTOMS. IS THERE A RELATIONSHIP? A CASE-CONTROL STUDY The Journal of Urology · 2010
    10. 5-α-Reductase inhibitors for prostate cancer chemoprevention: an updated Cochrane systematic review BJUI · 2010 · 44 citations
    11. Male pattern baldness and the risk of prostate cancer Annals of Oncology · 2011 · 38 citations
    12. Relationship of Early-Onset Baldness to Prostate Cancer in African-American Men Cancer Epidemiology, Biomarkers & Prevention · 2013 · 21 citations
    13. Male Pattern Baldness in Relation to Prostate Cancer–Specific Mortality: A Prospective Analysis in the NHANES I Epidemiologic Follow-up Study American Journal of Epidemiology · 2016 · 17 citations
    14. Androgen Receptor Polymorphism-Dependent Variation in Prostate-Specific Antigen Concentrations of European Men Cancer Epidemiology, Biomarkers & Prevention · 2014 · 9 citations
    15. Increased DHT levels in androgenic alopecia have been selected for to protect men from prostate cancer Medical Hypotheses · 2014 · 9 citations
    16. Oral administration of berberine represses macrophage activation-associated benign prostatic hyperplasia: a pivotal involvement of the NF-κB Aging · 2021 · 8 citations
    17. Interaction between estrogens and androgen receptor genes microsatellites, prostate-specific antigen and androgen receptor expressions in breast cancer Neoplasma · 2010 · 6 citations
    18. Effect of the ethanol extract of Syzygium aromaticum (clove) leaves on the lipid profile and body weight in testosterone-induced benign prostatic hyperplasia rats Global Translational Medicine · 2026
    19. The Risks and Benefits of 5α-Reductase Inhibitors for Prostate-Cancer Prevention 2011 · 147 citations
    20. The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications The Prostate · 1986 · 57 citations
    21. Risk of erectile dysfunction associated with use of 5-α reductase inhibitors for benign prostatic hyperplasia or alopecia: population based studies using the Clinical Practice Research Datalink BMJ · 2016 · 30 citations
    22. Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride Clinical Drug Investigation · 2018 · 20 citations
    23. Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction Hormone Molecular Biology and Clinical Investigation · 2017 · 20 citations
    24. Apocrine sweat gland obstruction by antiperspirants allowing transdermal absorption of cutaneous generated hormones and pheromones as a link to the observed incidence rates of breast and prostate cancer in the 20th century Medical Hypotheses · 2009 · 18 citations
    25. Is prostate-specific antigen a potential new marker of androgen excess in polycystic ovary syndrome? Journal of Obstetrics and Gynaecology Research · 2007 · 16 citations
    26. Prostate-Sparing Effects in Primates of the Potent Androgen 7α-Methyl-19-Nortestosterone: A Potential Alternative to Testosterone for Androgen Replacement and Male Contraception1 The Journal of Clinical Endocrinology and Metabolism · 1998 · 14 citations
    27. Rat steroid 5α-reductase kinetic characteristics: Extreme pH-dependency of the type II isozyme in prostate and epididymis homogenates The Journal of Steroid Biochemistry and Molecular Biology · 1995 · 13 citations
    28. Androgenetic alopecia at various ages and prostate cancer risk in an equal-access multiethnic case–control series of veterans Cancer Causes & Control · 2013 · 12 citations
    29. Circulating and intraprostatic sex steroid hormonal profiles in relation to male pattern baldness and chest hair density among men diagnosed with localized prostate cancers The Prostate · 2017 · 7 citations
    30. Prostate specific antigen (PSA) in diagnosis of polycystic ovarian syndrome – a new insight Gynecological Endocrinology · 2016 · 6 citations